IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf

Assessing options in hot ADC space

 
• By Anju Ghangurde
  
Cyril Konto, President and CEO, Ichnos Glenmark Innovation, • Source: Ichnos Glenmark Innovation
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip